Serial 1H-MRS in GM2 gangliosidoses

European Journal of Pediatrics

Volumn 167, Issue 3, 2008, Pages 347-352

  Assadi, Mitra ^a   Baseman, Susan ^a   Janson, Christopher ^a   Wang, Dah Jyuu ^b   Bilaniuk, Larissa ^b   Leone, Paola ^a  

^a UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

GM2 gangliosidoses; MR spectroscopy; N acetyl aspartate; Sandhoff disease; Tay Sachs disease

Indexed keywords

ARTICLE; CASE REPORT; CELL LOSS; CLINICAL ASSESSMENT; GENE INSERTION; GM2 GANGLIOSIDOSIS; HUMAN; LABORATORY TEST; MALE; MOEBIUS SYNDROME; MUSCLE HYPOTONIA; NERVE CELL; NUCLEAR MAGNETIC RESONANCE IMAGING; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; SEIZURE; STATISTICAL SIGNIFICANCE;

CONSANGUINITY; GANGLIOSIDOSES, GM2; HUMANS; INFANT; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MALE;

EID: 39049133338     PISSN: 03406199     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00431-007-0469-0     Document Type: Article

References (17)

1. Aydin K, Bakir B, Tatli B, Terzibasioglu E, Ozmen M (2005) Proton MR spectroscopy in three children with Tay-Sachs disease. Pediatr Radiol 35:1081-1085
2. Bitsch A, Bruhn H, Vougioukas V, Stringaris A, Lassmann H, Frahm J, Bruck W (1999) Inflammatory CNS demylination: histopathologic correlation with in vivo quantitative proton MR spectroscopy. AJNR Am J Neuroradiol 20:1619-1627
3. Brand A, Richter-Landsberg C, Liebfritz D (1993) Multinuclear NMR studies on the energy metabolism of glial and neuronal cells. Dev Neurosci 15:289-298
4. Fukumizu M, Yoshikawa H, Takashima S, Sakuragawa N, Kurokawa T (1992) Tay-Sachs disease: progression of changes on neuroimaging in four cases. Neuroradiology 34:483-486
5. Gravel RA, Kaback MM, Proia RL, Sandhoff K, Suzuki K, Suzuki K (2001) The GM2 gangliosidoses. In: Scriver CR (ed) The metabolic & molecular bases of inherited disease. McGraw-Hill, New York, pp 3827-3876
6. Haque AU (1995) Fine needle aspiration cytology of Tay-Sachs disease: a case report. Acta Cytol 39:762-765
7. Horská A, Kaufmann WE, Brant LJ, Naidu S, Harris JC, Barker PB (2002) In vivo quantitative proton MRSI study of brain development from childhood to adolescence. J Magn Reson Imaging 15:137-143
8. Huang J-Q, Trasler JM, Suleiman I, Michaud J, Hanai N, Gravel RA (1997) Apoptotic cell death in mouse models of GM2 gangliosidosis and observations on human Tay-Sachs and Sandhoff diseases. Hum Mol Genet 6:1879-1885
9. Inglese M, Nusbaum AO, Pastores GM, Gianutsos J, Kolodny EH, Gonen O (2005) MR imaging and proton spectroscopy of neuronal injury in late-onset GM2 gangliosidosis. AJNR Am J Neuroradiol 26:2037-2042
10. Lachmann RL, Platt FM (2001) Substrate reduction therapy for glycosphingolipid storage disorders. Expert Opin Investig Drugs 10:455-466
11. Lam WWM, Wang ZJ, Zhao H, Berry GT, Kaplan P, Gibson J, Kaplan BS, Bilaniuk LT, Hunter JV, Haselgrove JC, Zimmermann RA (1998) 1H MR spectroscopy of the basal ganglia in childhood: a semiquantitative analysis. Neuroradiology 40:315-323
12. Miller BL (1991) A review of chemical issues in NMR. NMR Biomed 4:47-52
13. Moriwaki S (1997) Histological observations of the brain of Tay-Sachs: report of an autopsy. Acta Pathologica 27:387-407
14. Mugikura S, Takahashi S, Higano S, Kurihara N, Kon K, Sakamoto K (1996) MR findings in Tay-Sachs disease. J Comput Assist Tomogr 20:551-555
15. Myerowitz R, Lawson D, Mizukami H, Mi Y, Tifft CJ, Proia RL (2002) Molecular pathophysiology in Tay-Sachs and Sandhoff diseases as revealed by gene expression profiling. Hum Mol Genet 11:1343-1351
16. Provencher SW (1993) Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magn Reson Med 30:672-679
17. Yamaguchi A, Katsuyama K, Suzuki K, Kosaka K, Aoki I, Yamanaka S (2003) Plasmid-based gene transfer ameliorates visceral storage in a mouse model of Sandhoff disease. J Mol Med 81:185-193